Dysregulation of platelet-derived growth factor β-receptor expression by ΔNp73 in neuroblastoma

Molecular Cancer Research

Volumn 7, Issue 12, 2009, Pages 2031-2039

  Wetterskog, Daniel ^a   Moshiri, Abtin ^a   Ozaki, Toshinori ^b   Uramoto, Hidetaka ^a,c   Nakagawara, Akira ^b   Funa, Keiko ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HISTONE DEACETYLASE 4; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN DELTA NP73; PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; RECEPTOR UPREGULATION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE DEACETYLASES; HUMANS; NEUROBLASTOMA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REPRESSOR PROTEINS; RNA, MESSENGER; SERUM; TUMOR SUPPRESSOR PROTEINS;

EID: 73849146560     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0501     Document Type: Article

References (30)

1. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
2. Liu P, Ying Y, Ko YG, Anderson RG. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 1996;271: 10299-303.
3. Sorkin A, Westermark B, Heldin CH, Claesson-Welsh L. Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF β-receptor. J Cell Biol 1991;112:469-78.
4. Mori S, Heldin CH, Claesson-Welsh L. Ligand-induced polyubiquitination of the platelet-derived growth factor β-receptor. J Biol Chem 1992;267:6429-34.
5. Oster SK, Marhin WW, Asker C, et al. Myc is an essential negative regulator of platelet-derived growth factor β receptor expression. Mol Cell Biol 2000;20: 6768-78.
6. Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor. J Cell Sci 2001;114: 1533-44.
7. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 1995;60:168-73.
8. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992;52:3213-9.
9. Hackzell A, Uramoto H, Izumi H, Kohno K, Funa K. p73 independent of c-Myc represses transcription of platelet-derived growth factor β-receptor through interaction with NF-Y. J Biol Chem 2002;277:39769-76.
10. Yang W, Wetterskog D, Matsumoto Y, Funa K. Kinetics of repression by modified p53 on the PDGF B-receptor promoter. Int J Cancer 2008;123:2020-30.
11. Uramoto H, Wetterskog D, Hackzell A, Matsumoto Y, Funa K. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF β-receptor. J Cell Sci 2004;117:5323-31.
12. Zaika AI, Slade N, Erster SH, et al. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002; 196:765-80.
13. Casciano I, Mazzocco K, Boni L, et al. Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 2002;9: 246-51.
14. Concin N, Becker K, Slade N, et al. Transdominant ΔTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res 2004;64:2449-60.
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science (New York, NY) 1991;253:49-53.
16. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A 1995;92:5520-4.
17. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
18. Grob TJ, Novak U, Maisse C, et al. Human δNp73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001;8: 1213-23.
19. Nakagawa T, Takahashi M, Ozaki T, et al. Autoinhibitory regulation of p73 by ΔNp73 to modulate cell survival and death through a p73-specific target element within the ΔNp73 promoter. Mol Cell Biol 2002;22:2575-85.
20. Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient ΔTA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 2002;277:14177-85.
21. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993;8: 307-18.
22. Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999;399: 806-9.
23. Million K, Horvilleur E, Goldschneider D, et al. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells. Int J Oncol 2006;29:147-54.
24. Goldschneider D, Million K, Meiller A, et al. The neurogene BTG2TIS21/ PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells. J Cell Sci 2005;118:1245-53.
25. Uramoto H, Hackzell A, Wetterskog D, Ballagi A, Izumi H, Funa K. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF β-receptor transcription. J Cell Sci 2004;117:3855-65.
26. 2/M promoters, via p53 C-terminal lysines. J Biol Chem 2006;281:2347-57.
27. Uramoto H, Sugio K, Oyama T, et al. Expression of ΔNp73 predicts poor prognosis in lung cancer. Clin Cancer Res 2004;10:6905-11.
28. Knights CD, Catania J, Di Giovanni S, et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 2006;173:533-44.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 156-9.
30. Hayashi S, Ozaki T, Yoshida K, et al. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53. Biochem Biophys Res Commun 2006;347:60-6.